Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • HCA vs GSK✓SelectedUSD · GSKHCA vs GSK performance historyLatest closeAs of+3.31%11/20
Stock and ETF performance explorer

HCA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+0.5%
GSK return
+6.1%
Excess return
-5.6%
Maximum drawdown
-33.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+3.3%-0.1%+3.4%+3.4%
7D-4.7%-5.3%+0.6%-2.4%
30D+3.5%-3.7%+7.2%+5.0%
3M+17.3%-7.3%+24.5%+20.8%
6M+20.4%-4.2%+24.6%+22.9%
YTD+2.4%+0.9%+1.5%+4.6%
1Y+0.5%+7.3%-6.7%+2.8%
All+0.5%+6.1%-5.6%+2.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling